HT
NVO

Heritage Trust’s Novo Nordisk NVO Stock Holding History

Heritage Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$316K Buy
2,216
+336
+18% +$44.5K 0.04% 234
2024
Q1 		$241K Sell
1,880
-342
-15% -$40.7K 0.03% 260
2023
Q4 		$230K Buy
+2,222
New +$220K 0.03% 254

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Heritage Trust's NVO Position: Q2 2024 in Review

Heritage Trust increased its Novo Nordisk (NVO) stake by 18% in Q2 2024, buying an estimated $44.5K and bringing the position to 2,216 shares worth $316K. The position accounts for 0.04% of the portfolio, ranked #234.

Heritage Trust first reported a position in NVO in Q4 2023 and has held it in 3 quarters since. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Heritage Trust held 2,216 shares of Novo Nordisk worth $316K as of Q2 2024.
  • Heritage Trust bought 336 Novo Nordisk shares in Q2 2024, an estimated $44.5K.
  • Novo Nordisk made up 0.04% of Heritage Trust's portfolio in Q2 2024, its #234 holding.
  • Heritage Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 3 quarters since.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Heritage Trust's 13F filing for Q2 2024, filed 12 Aug 2024.